Jane Street’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,717
Closed -$1.8M 10363
2022
Q4
$1.8M Buy
15,717
+50
+0.3% +$5.51K ﹤0.01% 4018
2022
Q3
$1.59M Sell
15,667
-45,361
-74% -$4.8M ﹤0.01% 4590
2022
Q2
$6.19M Buy
+61,028
New +$6.66M ﹤0.01% 2350
2020
Q3
Sell
-162,721
Closed -$17M 8184
2020
Q2
$17M Buy
+162,721
New +$17.4M 0.01% 846

Other funds holding BSX.PRA

Jane Street's BSX.PRA Position: Q1 2023 in Review

Jane Street sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q1 2023, closing a stake of 15,717 shares — an estimated $1.8M sold.

Jane Street first reported a position in BSX.PRA in Q2 2020 and held it in 4 quarters. The position peaked at $17M in Q2 2020. 56 funds tracked by Wall St. Rank hold BSX.PRA as of Q1 2023.

  • Jane Street reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 15,717 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q1 2023, an estimated $1.8M.
  • Jane Street first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 4 quarters.
  • Jane Street's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $17M in Q2 2020.
  • 56 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.